CN108203706A - A kind of helper adenovirus for being used to improve high capacity adenoviral packaging efficiency - Google Patents
A kind of helper adenovirus for being used to improve high capacity adenoviral packaging efficiency Download PDFInfo
- Publication number
- CN108203706A CN108203706A CN201711239774.XA CN201711239774A CN108203706A CN 108203706 A CN108203706 A CN 108203706A CN 201711239774 A CN201711239774 A CN 201711239774A CN 108203706 A CN108203706 A CN 108203706A
- Authority
- CN
- China
- Prior art keywords
- adenovirus
- cre
- base
- gene
- adenoviral
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y599/00—Other isomerases (5.99)
- C12Y599/01—Other isomerases (5.99.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
Abstract
The invention discloses a kind of for improving the helper adenovirus of high capacity adenoviral packaging efficiency, based on 5 type adenoviral gene groups, the DNA sequence dna between the DNA sequence dna and 27893bp to 30990bp between 5 type adenoviral gene group distance, 5 ' ends 193bp to 5196bp is eliminated;Loxp sequences, adenoviral packaging signal Ψ, Cre gene expression frame, loxp sequences are sequentially inserted between 5 type adenoviral gene group distance the 192nd, 5 ' ends base and the 5197th base;Between 5 type adenoviral gene group distance the 27892nd, 5 ' ends base and the 30991st base, it is inserted into pIX gene expression frames and IVa2 gene expression frames.By adding in Cre genes, under the CRE enzyme effects of incasing cells, while helper virus packaging signal Ψ is removed, the expression of the Cre genes entrained by helper virus itself is induced, improves the amount of CRE enzymes, the removal for making packaging signal Ψ is more thorough.The genome structure of helper virus is adjusted simultaneously, avoids helping virus and the virus genomic recombination in incasing cells and the generation of wild-type virus.
Description
Technical field
The invention belongs to biotechnologies, are related to a kind of helper adenovirus, more particularly to a kind of to be used to improve high power capacity
The helper adenovirus of adenovirus packaging efficiency.
Background technology
It is to pass through viral vectors by the foreign gene importing most effective means of target cell at present in gene therapy.Often
Viral vectors includes adenovirus vector, gland relevant viral vector, slow virus carrier etc..Gland relevant viral vector has immune
Originality is low, not radom insertion chromosome the advantages that, but its capacity is too small, is restricted in use.Slow virus carrier due to
Meeting radom insertion chromosome, easily causes cancer, safety is under suspicion.Adenovirus vector has high power capacity, high titre, not whole
The advantages that being incorporated into chromosome, but its immunogenicity is high, easily causes stronger immune response in treating in vivo.Development at present
The third-generation adenovirus vectors to get up remove the most gene group of adenovirus, only remain its member that is used to replicate and pack
Part ITR and Ψ, thus greatly reduce its immunogenicity.It is considered as a kind of viral vectors very with application prospect.
Due to eliminating most virus genome sequence, the packaging of third-generation adenovirus needs helper virus to provide
Various capsid proteins needed for packaging, while need to avoid being polluted by helper virus again.Currently used removal auxiliary disease
In the method for poison, effect in the both sides of its packaging signal Ψ it is preferable to add in loxp sequences, in auxiliary high capacity adenoviral
In packaging process, packaging signal Ψ is removed after loxp sequences by CRE enzyme effects expressed in incasing cells, so as to make
Obtaining helper virus genome can not be packaged.But due to CRE expression quantity deficiency in these methods and in packaging process
Helper virus may occur recombination with fractionated viral genome sequence included in incasing cells and form wild-type virus, because
This, helper virus can not preferably remove from packaging virus, still remain certain pollution.Currently without better method
Make the pollution of helper virus further reduce.
Invention content
For the polluted technical problem of above-mentioned helper adenovirus, the object of the present invention is to provide a kind of new energy
Enough helper adenovirus for more efficiently removing packaging signal and avoiding generating wild-type virus.
In order to realize above-mentioned task, the present invention takes following technical solution:
A kind of helper adenovirus for being used to improve high capacity adenoviral packaging efficiency, which is characterized in that with 5 type adenovirus bases
Based on group, the DNA sequence dna and 27893bp that eliminate between 5 type adenoviral gene group distance, 5 ' ends 193bp to 5196bp arrive
DNA sequence dna between 30990bp;Between 5 type adenoviral gene group distance the 192nd, 5 ' ends base and the 5197th base according to
Secondary insertion loxp sequences, adenoviral packaging signal Ψ, Cre gene expression frame, loxp sequences, two loxp sequences directions of insertion
It is consistent;Between 5 type adenoviral gene group distance the 27892nd, 5 ' ends base and the 30991st base, it is inserted into pIX bases
Because of expression cassette and IVa2 gene expression frames.
According to the present invention, the adenoviral packaging signal Ψ is the packaging signal of 5 type adenovirus, specially 5 type adenopathies
Virus gene group distance the 193rd, 5 ' ends base is to the DNA sequence dna between the 440th base, and direction is forward or backwards.
The Cre gene expression frames are made of promoter, Cre genes, terminator;Wherein, Cre gene orders include N
Terminal sequence, C-terminal sequence, introne shearing donor sequences, introne shearing receptor sequence, N-terminal sequence is 5 ' of Cre gene coding regions
The DNA fragmentation that 4 bases in end are grown to 1049 bases, C-terminal sequence are Cre gene coding regions 4,3 ' ends base to 1049 alkali
The DNA fragmentation of base length is inserted into one section of introne shearing donor sequences at 3 ' ends of N-terminal sequence, one is inserted at 5 ' ends of C-terminal sequence
Section introne shearing receptor sequence, introne shearing donor sequences and shearing receptor sequence total length are no more than 500bp;Introne
Shear donor sequences, Cre gene N-terminals sequence, promoter, terminator, Cre gene Cs terminal sequence, introne shearing receptor sequence according to
The secondary direction according to 3 ' to 5 ' is inserted into the 3 ' ends of adenoviral packaging signal Ψ.
Above-mentioned Cre gene expression frames sequence is as follows:
AAACGCAAGAGTCTTCTCTGTCTCGACAAGCCCAGTTTCTATTGGTCTCCTTAAACCTGTCTTGTAACCTTGATACT
TACCTGGTCGAAATCAGTGCGTTCGAACGCTAGAGCCTGTTTTGCACGTTCACCGGCATCAACGTTTTCTTTTCGGA
TCCGCCGCATAACCAGTGAAACAGCATTGCTGTCACTTGGTCGTGGCAGCCCGGACCGACGATGAAGCATGTTTAGC
TGGCCCAAATGTTGCTGGATAGTTTTTACTGCCAGACCGCGCGCCTGAAGATATAGAAGATAATCGCGAACATCTTC
AGGTTCTGCGGGAAACCATTTCCGGTTATTCAACTTGCACCATGCCGCCCACGACCGGCAAACGGACAGAAGCATTT
TCCAGGTATGCTCAGAAAACGCCTGGCGATCCCTGAACATGTCCATCAGGTTCTTGCGAACCTCATCACTCGTTGCA
TCGACCGGTAATGCAGGCAAATTTTGGTGTACGGTCAGTAAATTGGACACCTTCCTCTTCTTCTTGGGCATGGTGGC
ATCTGACGGTTCACTAAACGAGCTCTGCTTATATAGACCTCCCACCGTACACGCCTACCGCCCATTTGCGTCAATGG
GGCGGAGTTGTTACGACATTTTGGAAAGTCCCGTTGATTTTGGTGCCAAAACAAACTCCCATTGACGTCAATGGGGT
GGAGACTTGGAAATCCCCGTGAGTCAAACCGCTATCCACGCCCATTGATGTACTGCCAAAACCGCATCACCATGGTA
ATAGCGATGACTAATACGTAGATGTACTGCCAAGTAGGAAAGTCCCATAAGGTCATGTACTGGGCATAATGCCAGGC
GGGCCATTTACCGTCATTGACGTCAATAGGGGGCGTACTTGGCATATGATACACTTGATGTACTGCCAAGTGGGCAG
TTTACCGTAAATACTCCACCCATTGACGTCAATGGAAAGTCCCTATTGGCGTTACTATGGGAACATACGTCATTATT
GACGTCAATGGGCGGGGGTCGTTGGGCGGTCAGCCAGGCGGGCCATTTACCGTAAGTTATGTAACGCCACCGCGGGG
ACTAGAGTCGACCTCATGGCTGCGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCC
GGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAAGAGGTTTTCACCGTCATCACCGAAA
CGCGCGAGGCAGCCGGGATCATAATCAGCCATACCACATTTGTAGAGGTTTTACTTGCTTTAAAAAACCTCCCACAC
CTCCCCTGAACCTGAAACATAAAATGAATGCAATTGTTGTTGTTAACTTGTTTATTGCAGCTTATAATGGTTACAAA
TAAAGCAATAGCATCACAAATTTCACAAATAAAGCATTTTTTTCACTGCATTCTAGTTGTGGTTTGTCCAAACTCAT
CAATGTATCTTATCATGTCTGGATCTCCCCGCGGTGCTAATCGCCATCTTCCAGCAGGCGCACCATTGCCCCTGTTT
CACTATCCAGGTTACGGATATAGTTCATGACAATATTTACATTGGTCCAGCCACCAGCTTGCATGATCTCCGGTATT
GAAACTCCAGCGCGGGCCATATCTCGCGCGGCTCCGACACGGGCACTGTGTCCAGACCAGGCCAGGTATCTCTGACC
AGAGTCATCCTTAGCGCCGTAAATCAATCGATGAGTTGCTTCAAAAATCCCTTCCAGGGCGCGAGTTGATAGCTGGC
TGGTGGCAGATGGCGCGGCAACACCATTTTTTCTGACCCGGCAAAACAGGTAGTTATTCGGATCATCAGCTACACCA
GAGACGGAAATCCATCGCTCGACCAGTTTAGTTACCCCCAGGCTAAGTGCCTTCTCTACACCTGCGGTGCTAACCAG
CGTTTTCGTTCTGCCAATATGGATTAACATTCTCCCACCGTCAGTACGTGAGATATCTTTAACCCTGATCCTGGCAA
TTTCGGCTATACGTAACAGGGTGTTATAAGCAATCCCCAGAAATGCCAGATTACGTATATCCTGGCAGCGATCGCTA
TTTTCCATGAGTGAACGAACCTGTGGAGAGAAAGGCAAAGTGGATGTCAGTAAGACCAATAGGTGCCTATCAT。
Further, the pIX gene expression frames are at 5 ' ends of the pIX gene coding regions of 5 type adenovirus and 3 ' ends
It is separately added into promoter and terminator;The IVa2 gene expressions are at 5 ' ends of the IVa2 gene coding regions of 5 type adenovirus
Promoter and terminator are separately added into 3 ' ends.
The promoter is eukaryotic promoter, and the terminator is eucaryon terminator.
The promoter is any one in CMV, EF1 α, PGK, SV40, CAG, Tet on, Tet off, described
Terminator is any one in SV40pA, BGHpA, TKpA, hGHpA.
Provided by the present invention for improving the helper adenovirus of high capacity adenoviral packaging efficiency, by helper adenovirus
Middle addition Cre genes, under the CRE enzyme effects of incasing cells, while helper virus packaging signal Ψ is removed, induction auxiliary
The expression of Cre genes entrained by virus itself, so as to improve the amount of CRE enzymes, the removal for making packaging signal Ψ is more thorough.Together
When the genome structure of helper virus is adjusted, avoid helper virus with it is virus genomic heavy in incasing cells
Group, so as to avoid the generation of wild-type virus.The pollution of helper virus is further reduced by the two aspects.So as to obtain
Obtain the higher high capacity adenoviral of purity.
Description of the drawings
Fig. 1 is Ad helper1 structures and action principle figure.
Fig. 2 is that helper adenovirus packs the lesion picture to be formed.
Fig. 3 is helper adenovirus packaging signal removal effect testing result figure.
Fig. 4 is helper adenovirus pollution detection result figure.
The present invention is described in more detail with reference to the accompanying drawings and examples.
Specific embodiment
Applicant is sequentially inserted between 5 type adenoviral gene group distance the 192nd, 5 ' ends base and the 5197th base
Loxp sequences, adenoviral packaging signal Ψ, Cre gene expression frame, loxp sequences, so that in the adenovirus of expression CRE enzymes
In incasing cells, helper adenovirus induces the expression of itself Cre gene, so as to carry while itself packaging signal Ψ is removed
The amount of CRE enzymes in high incasing cells so that packaging signal Ψ removals are more thorough.Simultaneously by pIX bases in 5 type adenoviral gene groups
Because expression cassette and IVa2 gene expression frames have been moved to distance the 27892nd, 5 ' ends base and the 30991st alkali from original position
Between base, so as to avoid fractionated viral genome sequence weight present in helper adenovirus genes group and incasing cells genome
Group generates the possibility of wild-type virus.It is caused by improving helper adenovirus above when high capacity adenoviral is assisted to pack
Helper virus pollution further reduce.
It is the embodiment that inventor provides below, it should be noted that these embodiments are only the preferred implementations of the present invention
Mode, the present invention is not limited to these Examples.
Embodiment 1:
For from the helper adenovirus Ad helper1 for removing packaging signal and pIX gene controlled expressions, the auxiliary gland
Organization of viral genome is as follows:
Based on 5 type adenoviral gene groups, 5 type adenoviral gene group sequence NCBI numbers are AC_000008.Removal
Between DNA sequence dna and 27893bp to 30990bp in 5 type adenoviral gene groups between distance 5 ' ends 193bp to 5196bp
DNA sequence dna;Loxp sequences are sequentially inserted between 5 type adenoviral gene group distance the 192nd, 5 ' ends base and the 5197th base
Row, adenoviral packaging signal Ψ, Cre gene expression frame, loxp sequences, two loxp sequences directions of insertion are consistent;5
PIX gene expression frames and IVa2 are inserted between type adenoviral gene group distance the 27892nd, 5 ' ends base and the 30991st base
Gene expression frame.
Adenoviral packaging signal Ψ is placed to be positive, and the 193rd, 5 ' ends of specially 5 type adenoviral gene group distance base arrives
DNA sequence dna between 440th base.
DNA fragmentation of the Cre gene N-terminals sequence for 5 ' ends of Cre gene coding regions, 453 base length, Cre gene C terminal sequences
DNA fragmentation for 3 ' ends of Cre gene coding regions, 600 base length.
The DNA sequence dna being inserted between 5 type adenoviral gene group distance the 192nd, 5 ' ends base and the 5197th base is such as
Under:
ATAACTTCGTATAATGTATGCTATACGAAGTTATTACACAGGAAGTGACAATTTTCGCGCGGTTTTAGGCGGATGTT
GTAGTAAATTTGGGCGTAACCGAGTAAGATTTGGCCATTTTCGCGGGAAAACTGAATAAGAGGAAGTGAAATCTGAA
TAATTTTGTGTTACTCATAGCGCGTAATATTTGTCTAGGGCCGCGGGGACTTTGACCGTTTACGTGGAGACTCGCCC
AGGTGTTTTTCTCAGGTGTTTTCCGCGTTCCGGGTCAAAGTTGGCGTTTTAAACGCAAGAGTCTTCTCTGTCTCGAC
AAGCCCAGTTTCTATTGGTCTCCTTAAACCTGTCTTGTAACCTTGATACTTACCTGGTCGAAATCAGTGCGTTCGAA
CGCTAGAGCCTGTTTTGCACGTTCACCGGCATCAACGTTTTCTTTTCGGATCCGCCGCATAACCAGTGAAACAGCAT
TGCTGTCACTTGGTCGTGGCAGCCCGGACCGACGATGAAGCATGTTTAGCTGGCCCAAATGTTGCTGGATAGTTTTT
ACTGCCAGACCGCGCGCCTGAAGATATAGAAGATAATCGCGAACATCTTCAGGTTCTGCGGGAAACCATTTCCGGTT
ATTCAACTTGCACCATGCCGCCCACGACCGGCAAACGGACAGAAGCATTTTCCAGGTATGCTCAGAAAACGCCTGGC
GATCCCTGAACATGTCCATCAGGTTCTTGCGAACCTCATCACTCGTTGCATCGACCGGTAATGCAGGCAAATTTTGG
TGTACGGTCAGTAAATTGGACACCTTCCTCTTCTTCTTGGGCATGGTGGCATCTGACGGTTCACTAAACGAGCTCTG
CTTATATAGACCTCCCACCGTACACGCCTACCGCCCATTTGCGTCAATGGGGCGGAGTTGTTACGACATTTTGGAAA
GTCCCGTTGATTTTGGTGCCAAAACAAACTCCCATTGACGTCAATGGGGTGGAGACTTGGAAATCCCCGTGAGTCAA
ACCGCTATCCACGCCCATTGATGTACTGCCAAAACCGCATCACCATGGTAATAGCGATGACTAATACGTAGATGTAC
TGCCAAGTAGGAAAGTCCCATAAGGTCATGTACTGGGCATAATGCCAGGCGGGCCATTTACCGTCATTGACGTCAAT
AGGGGGCGTACTTGGCATATGATACACTTGATGTACTGCCAAGTGGGCAGTTTACCGTAAATACTCCACCCATTGAC
GTCAATGGAAAGTCCCTATTGGCGTTACTATGGGAACATACGTCATTATTGACGTCAATGGGCGGGGGTCGTTGGGC
GGTCAGCCAGGCGGGCCATTTACCGTAAGTTATGTAACGCCACCGCGGGGACTAGAGTCGACCTCATGGCTGCGCCC
CGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGAC
CGTCTCCGGGAGCTGCATGTGTCAAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGCCGGGATCATAATCA
GCCATACCACATTTGTAGAGGTTTTACTTGCTTTAAAAAACCTCCCACACCTCCCCTGAACCTGAAACATAAAATGA
ATGCAATTGTTGTTGTTAACTTGTTTATTGCAGCTTATAATGGTTACAAATAAAGCAATAGCATCACAAATTTCACA
AATAAAGCATTTTTTTCACTGCATTCTAGTTGTGGTTTGTCCAAACTCATCAATGTATCTTATCATGTCTGGATCTC
CCCGCGGTGCTAATCGCCATCTTCCAGCAGGCGCACCATTGCCCCTGTTTCACTATCCAGGTTACGGATATAGTTCA
TGACAATATTTACATTGGTCCAGCCACCAGCTTGCATGATCTCCGGTATTGAAACTCCAGCGCGGGCCATATCTCGC
GCGGCTCCGACACGGGCACTGTGTCCAGACCAGGCCAGGTATCTCTGACCAGAGTCATCCTTAGCGCCGTAAATCAA
TCGATGAGTTGCTTCAAAAATCCCTTCCAGGGCGCGAGTTGATAGCTGGCTGGTGGCAGATGGCGCGGCAACACCAT
TTTTTCTGACCCGGCAAAACAGGTAGTTATTCGGATCATCAGCTACACCAGAGACGGAAATCCATCGCTCGACCAGT
TTAGTTACCCCCAGGCTAAGTGCCTTCTCTACACCTGCGGTGCTAACCAGCGTTTTCGTTCTGCCAATATGGATTAA
CATTCTCCCACCGTCAGTACGTGAGATATCTTTAACCCTGATCCTGGCAATTTCGGCTATACGTAACAGGGTGTTAT
AAGCAATCCCCAGAAATGCCAGATTACGTATATCCTGGCAGCGATCGCTATTTTCCATGAGTGAACGAACCTGTGGA
GAGAAAGGCAAAGTGGATGTCAGTAAGACCAATAGGTGCCTATCATATAACTTCGTATAATGTATGCTATACGAAGT
TAT。
The pIX bases being inserted between 5 type adenoviral gene group distance the 27892nd, 5 ' ends base and the 30991st base
Because expression cassette and IVa2 gene expression frames are as follows:
GTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGACGTA
TGTTCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCACTTGG
CAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCATTAT
GCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGGTGAT
GCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCATTGACG
TCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGACGCAA
ATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATATGAGCACCAAC
TCGTTTGATGGAAGCATTGTGAGCTCATATTTGACAACGCGCATGCCCCCATGGGCCGGGGTGCGTCAGAATGTGAT
GGGCTCCAGCATTGATGGTCGCCCCGTCCTGCCCGCAAACTCTACTACCTTGACCTACGAGACCGTGTCTGGAACGC
CGTTGGAGACTGCAGCCTCCGCCGCCGCTTCAGCCGCTGCAGCCACCGCCCGCGGGATTGTGACTGACTTTGCTTTC
CTGAGCCCGCTTGCAAGCAGTGCAGCTTCCCGTTCATCCGCCCGCGATGACAAGTTGACGGCTCTTTTGGCACAATT
GGATTCTTTGACCCGGGAACTTAATGTCGTTTCTCAGCAGCTGTTGGATCTGCGCCAGCAGGTTTCTGCCCTGAAGG
CTTCCTCCCCTCCCAATGCGGTTTAAAACATAAATAAAAAACCAGACTCTGTTTGGATTTGGATCAAGCAAGTGTCT
TGCTGTCTTTATTTAGGGGTTTTGCGCGCGCGGTAGGCCCGGGACCAGCGGTCTCGGTCGTTGAGGGTCCTGTGTAT
TTTTTCCAGGACGTGGTAAAGGTGACTCTGGATGTTCAGATACATGGGCATAAGCCCGTCTCTGGGGTGGAGGTAGC
ACCACTGCAGAGCTTCATGCTGCGGGGTGGTGTTGTAGATGATCCAGTCGTAGCAGGAGCGCTGGGCGTGGTGCCTA
AAAATGTCTTTCAGTAGCAAGCTGATTGCCAGGGGCAGGCCCTTGGTGTAAGTGTTTACAAAGCGGTTAAGCTGGGA
TGGGTGCATACGTGGGGATATGAGATGCATCTTGGACTGTATTTTTAGGTTGGCTATGTTCCCAGCCATATCCCTCC
GGGGATTCATGTTGTGCAGAACCACCAGCACAGTGTATCCGGTGCACTTGGGAAATTTGTCATGTAGCTTAGAAGGA
AATGCGTGGAAGAACTTGGAGACGCCCTTGTGACCTCCAAGATTTTCCATGCATTCGTCCATAATGATGGCAATGGG
CCCACGGGCGGCGGCCTGGGCGAAGATATTTCTGGGATCACTAACGTCATAGTTGTGTTCCAGGATGAGATCGTCAT
AGGCCATTTTTACAAAGCGCGGGCGGAGGGTGCCAGACTGCGGTATAATGGTTCCATCCGGCCCAGGGGCGTAGTTA
CCCTCACAGATTTGCATTTCCCACGCTTTGAGTTCAGATGGGGGGATCATGTCTACCTGCGGGGCGATGAAGAAAAC
GGTTTCCGGGGTAGGGGAGATCAGCTGGGAAGAAAGCAGGTTCCTGAGCAGCTGCGACTTACCGCAGCCGGTGGGCC
CGTAAATCACACCTATTACCGGGTGCAACTGGTAGTTAAGAGAGCTGCAGCTGCCGTCATCCCTGAGCAGGGGGGCC
ACTTCGTTAAGCATGTCCCTGACTCGCATGTTTTCCCTGACCAAATCCGCCAGAAGGCGCTCGCCGCCCAGCGATAG
CAGTTCTTGCAAGGAAGCAAAGTTTTTCAACGGTTTGAGACCGTCCGCCGTAGGCATGCTTTTGAGCGTTTGACCAA
GCAGTTCCAGGCGGTCCCACAGCTCGGTCACCTGCTCTACGGCATCTCGATCCAGCATATCTCCTCGTTTCGCGGGT
TGGGGCGGCTTTCGCTGTACGGCAGTAGTCGGTGCTCGTCCAGACGGGCCAGGGTCATGTCTTTCCACGGGCGCAGG
GTCCTCGTCAGCGTAGTCTGGGTCACGGTGAAGGGGTGCGCTCCGGGCTGCGCGCTGGCCAGGGTGCGCTTGAGGCT
GGTCCTGCTGGTGCTGAAGCGCTGCCGGTCTTCGCCCTCTGGTTTCCATGGGCTGCAGGTCGAAAGGCCCGGAGATG
AGGAAGAGGAGAACAGCGCGGCAGACGTGCGCTTTTGAAGCGTGCAGAATGCCGGGCCTCCGGAGGACCTTCGGGCG
CCCGCCCCGCCCCTGAGCCCGCCCCTGAGCCCGCCCCCGGACCCACCCCTTCCCAGCCTCTGAGCCCAGAAAGCGAA
GGAGCAAAGCTGCTATTGGCCGCTGCCCCAAAGGCCTACCCGCTTCCATTGCTCAGCGGTGCTGTCCATCTGCACGA
GACTAGCTAGTAGTGAGACGTGCTACTCCCATTTGTCACGTCCTGCACGACGCGAGCTGCGGGGCGGGGGGGAACTT
CCTGACTAGGGGAGGAGTAGAAGGTGGCGCGAAGGGGCCACCAAAGAACGGAGCCGGTTGGCGCCTACCGGTGGATG
TGGAATGTGTGCGAGGCCAGAGGCCACTTGTGTAGCGCCAAGTGCCCAGCGGGGCTGCTAAAGCGCATGCTCCAGAC
TGCCTTGGGAAAAGCGCCTCCCCTACCCGGTAT。
Shown in the Organization of viral genome and action principle as attached drawing 1.
Helper adenovirus Ad helper1 building process is as follows:
(1) structure of the helper adenovirus E3 areas shuttle vector of pIX and IVa2 expression cassettes is carried
In Huada gene company synthetic primer, sequence is as follows:
P1EPXN for:AATTTTAATTAATTCTCGAGAATCGATAAGCGGCCGC;
P2EPXN reverse:AGCTGCGGCCGCTTATCGATTCTCGAGAATTAATTAA;
EPXN linker (EcoRI M-PacI-XhoI-ClaI-NotI- will be formed after above two primer annealings
HindIIIM), EPXN linker with the pUC19 carriers by EcoRI and HindIII digestions processing are connect, obtains pUC19/
EPXN。
By Huada gene company synthetic primer, sequence is as follows:
P3E3up PacI for:ATTAATTAAatcgacccgcgagcttagaaacag;
P4E3up XhoI reverse:ACTCGAGtttcaggcgcagttgctctgcctc;
P5E3down ClaI for:AATCGATgtttcctcctgttcctgtccatc;
P6E3down NotI reverse:AGCGGCCGCtgagctgcccggggagtttatt;
Respectively using P3/P4 and P5/P6 as primer, 5 type adenoviral gene group position templates, PCR amplification amplification obtain E3 up and
E3 down.E3up and E3 down are handled with PacI/XhoI and ClaI/NotI digestions respectively and recycle segment, with being connected into successively
The pUC19/EPXN carriers handled with similary digestion obtain phelperE3 shuttle.
Following primer is synthesized by Huada gene company:
CMV XhoI for:ACTCGAGGTTACATAACTTACGGTAAATGGC;
CMV pIX overlap reverse:
ttccatcaaacgagttggtgctcatATCTGACGGTTCACTAAACGAGCTCT;
pIX for:atgagcaccaactcgtttgatggaa;
IVa2reverse:atggaaaccagagggcgaagaccggcagcgct;
EF1αClaI for:AATCGATAAGGATCTGCGATCGCTCCGGTGCCCG;
EF1αIVa2overlap reverse:
AGCGCTGCCGGTCTTCGCCCTCTGGTTTCCATGGTGGCGTCTAGCGTAGGCGC。
Using 5 type adenoviral gene groups, CMV promoter, EF1 α promoters as template, CMV- is obtained by overlapping PCR method
PIX-IVa2-EF1 α segments with XhoI and ClaI digestions and recycle CMV-pIX-IVa2-EF1 α segments, with passing through similary digestion
The phelperE3shuttle connections of processing obtain phelperE3/CMV-pIX-IVa2-EF1 α.
(2) structure of the adenovirus E 1 area shuttle vector of ITR-loxp- Ψ-cre-loxp elements is carried
Following primer is synthesized by Huada gene company:
helperE1down ClaII for:AATCGATctacggcatctcgatccagcata;
helperE1down NotI reverse:AGCGGCCGCgggccaggtgaatatcaaatc.
Using 5 type adenoviral gene groups as template, PCR amplification obtains helperE1 down segments, with ClaI and NotI digestions
And helperE1down segments are recycled, it is connect with the pUC19/EPXN carriers by similary digestion processing, obtains helper adenovirus
E1 areas shuttle vector phelperE1 shuttle.
Following DNA fragmentation ITR-loxp- Ψ-cre-loxp are synthesized by Huada gene company, sequence is as follows:
TTAATTAAcatcatcaataatataccttattttggattgaagccaatatgataatgagggggtggagtttgtgacgt
ggcgcggggcgtgggaacggggcgggtgacgtagtagtgtggcggaagtgtgatgttgcaagtgtggcggaacacat
gtaagcgacggatgtggcaaaagtgacgtttttggtgtgcgccggtgATAACTTCGTATAATGTATGCTATACGAAG
TTATTACACAGGAAGTGACAATTTTCGCGCGGTTTTAGGCGGATGTTGTAGTAAATTTGGGCGTAACCGAGTAAGAT
TTGGCCATTTTCGCGGGAAAACTGAATAAGAGGAAGTGAAATCTGAATAATTTTGTGTTACTCATAGCGCGTAATAT
TTGTCTAGGGCCGCGGGGACTTTGACCGTTTACGTGGAGACTCGCCCAGGTGTTTTTCTCAGGTGTTTTCCGCGTTC
CGGGTCAAAGTTGGCGTTTTAAACGCAAGAGTCTTCTCTGTCTCGACAAGCCCAGTTTCTATTGGTCTCCTTAAACC
TGTCTTGTAACCTTGATACTTACCTGGTCGAAATCAGTGCGTTCGAACGCTAGAGCCTGTTTTGCACGTTCACCGGC
ATCAACGTTTTCTTTTCGGATCCGCCGCATAACCAGTGAAACAGCATTGCTGTCACTTGGTCGTGGCAGCCCGGACC
GACGATGAAGCATGTTTAGCTGGCCCAAATGTTGCTGGATAGTTTTTACTGCCAGACCGCGCGCCTGAAGATATAGA
AGATAATCGCGAACATCTTCAGGTTCTGCGGGAAACCATTTCCGGTTATTCAACTTGCACCATGCCGCCCACGACCG
GCAAACGGACAGAAGCATTTTCCAGGTATGCTCAGAAAACGCCTGGCGATCCCTGAACATGTCCATCAGGTTCTTGC
GAACCTCATCACTCGTTGCATCGACCGGTAATGCAGGCAAATTTTGGTGTACGGTCAGTAAATTGGACACCTTCCTC
TTCTTCTTGGGCATGGTGGCATCTGACGGTTCACTAAACGAGCTCTGCTTATATAGACCTCCCACCGTACACGCCTA
CCGCCCATTTGCGTCAATGGGGCGGAGTTGTTACGACATTTTGGAAAGTCCCGTTGATTTTGGTGCCAAAACAAACT
CCCATTGACGTCAATGGGGTGGAGACTTGGAAATCCCCGTGAGTCAAACCGCTATCCACGCCCATTGATGTACTGCC
AAAACCGCATCACCATGGTAATAGCGATGACTAATACGTAGATGTACTGCCAAGTAGGAAAGTCCCATAAGGTCATG
TACTGGGCATAATGCCAGGCGGGCCATTTACCGTCATTGACGTCAATAGGGGGCGTACTTGGCATATGATACACTTG
ATGTACTGCCAAGTGGGCAGTTTACCGTAAATACTCCACCCATTGACGTCAATGGAAAGTCCCTATTGGCGTTACTA
TGGGAACATACGTCATTATTGACGTCAATGGGCGGGGGTCGTTGGGCGGTCAGCCAGGCGGGCCATTTACCGTAAGT
TATGTAACGCCACCGCGGGGACTAGAGTCGACCTCATGGCTGCGCCCCGACACCCGCCAACACCCGCTGACGCGCCC
TGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAAGAGGT
TTTCACCGTCATCACCGAAACGCGCGAGGCAGCCGGGATCATAATCAGCCATACCACATTTGTAGAGGTTTTACTTG
CTTTAAAAAACCTCCCACACCTCCCCTGAACCTGAAACATAAAATGAATGCAATTGTTGTTGTTAACTTGTTTATTG
CAGCTTATAATGGTTACAAATAAAGCAATAGCATCACAAATTTCACAAATAAAGCATTTTTTTCACTGCATTCTAGT
TGTGGTTTGTCCAAACTCATCAATGTATCTTATCATGTCTGGATCTCCCCGCGGTGCTAATCGCCATCTTCCAGCAG
GCGCACCATTGCCCCTGTTTCACTATCCAGGTTACGGATATAGTTCATGACAATATTTACATTGGTCCAGCCACCAG
CTTGCATGATCTCCGGTATTGAAACTCCAGCGCGGGCCATATCTCGCGCGGCTCCGACACGGGCACTGTGTCCAGAC
CAGGCCAGGTATCTCTGACCAGAGTCATCCTTAGCGCCGTAAATCAATCGATGAGTTGCTTCAAAAATCCCTTCCAG
GGCGCGAGTTGATAGCTGGCTGGTGGCAGATGGCGCGGCAACACCATTTTTTCTGACCCGGCAAAACAGGTAGTTAT
TCGGATCATCAGCTACACCAGAGACGGAAATCCATCGCTCGACCAGTTTAGTTACCCCCAGGCTAAGTGCCTTCTCT
ACACCTGCGGTGCTAACCAGCGTTTTCGTTCTGCCAATATGGATTAACATTCTCCCACCGTCAGTACGTGAGATATC
TTTAACCCTGATCCTGGCAATTTCGGCTATACGTAACAGGGTGTTATAAGCAATCCCCAGAAATGCCAGATTACGTA
TATCCTGGCAGCGATCGCTATTTTCCATGAGTGAACGAACCTGTGGAGAGAAAGGCAAAGTGGATGTCAGTAAGACC
AATAGGTGCCTATCATATAACTTCGTATAATGTATGCTATACGAAGTTATCTCGAG。
ITR-loxp- Ψ-cre-loxp are handled with PacI and XhoI digestions, with passing through similary digestion processing
PhelperE1 shuttle carriers connect, and obtain the adenovirus E 1 area shuttle load for carrying ITR-loxp- Ψ-cre-loxp elements
Body phelperE1/ITR-loxp- Ψ-cre-loxp.
(3) structure of helper adenovirus Ad helper1
PhelperE3/CMV-pIX-IVa2-EF1 α are handled with PacI digestions, SwaI is introduced with SwaI digestions processing E3 areas
The adenoviral backbone carrier pAd5 backbone in site (carry the adenopathy of Zinc finger nuclease Expression element and donor dna in patent
Its disclosed preparation method in poison and its construction method and application), will treated plasmid cotransformation to E.coli BJ5183
Middle carry out homologous recombination obtains pAd5/CMV-pIX-IVa2-EF1 α.
PAd5/CMV-pIX-IVa2-EF1 α and phelperE1/ITR-loxp- Ψ-cre-loxp are handled with PacI digestions,
Later by the two cotransfection to HEK293 cells, visible lesion is formed after 7-8 days, which packs the lesion to be formed
See attached drawing 2, illustrate that helper adenovirus Ad helper1 are successfully packed.By amplification repeatedly, expand to 10 150mm cells and train
After supporting ware, virus is collected, uses Cscl2Density gradient centrifugation purified virus.
Stablize the adenovirus packaging cell HEK293-cre of expression CRE enzymes with the Ad helper1 infection of 8MOI, use simultaneously
Traditional helper adenovirus Ad helper of 8MOI infect another disk HEK293-cre, collect cell after 48 hours, are examined by PCR
The removal effect of packaging signal is surveyed, as a result sees attached drawing 3, after smaller electrophoretic band is packaging signal removal in experimental result
PCR product, and the PCR product that larger electrophoretic band is packaging signal when not removing, the packaging of visible Ad helper1 in figure
Signal removal is more thorough.
With 4MOI Ad helper1 and 4MOI Ad eGFP (normal adenovirus for carrying eGFP genes) coinfection
HEK293-cre cells, while with another disk HEK293-cre cells of 4MOI Ad helper and 4MOI Ad eGFP coinfections,
Virus infection U87 cells are collected after 48 hours, infection collects U87 cell extraction genomic DNAs after 24 hours, passes through Realtime
PCR detects the pollution of helper virus, as a result sees attached drawing 4, and Ad helper1 pollute lower than Ad helper as seen from Figure 4.
Helper adenovirus Ad helper1 application methods are as follows:
By high capacity adenoviral vector pHCAD PacI linearization for enzyme restriction, 60mm is transfected by coprecipitation of calcium phosphate and is put down
HEK293-cre cells in ware, with after 4MOI helper adenovirus Ad helper1 infection pHCAD transfections after 18 hours
After HEK293-cre, 48-72 hours, cell is collected, by 3 multigelations, supernatant is collected, obtains virus.Take 1/4 collection
Employing virus cracking liquid and 4MOI helper adenovirus Ad helper1 coinfections collect cell acquisition after HEK293-cre, 48-72 hours
Virus.Such repeated amplification virus passes through Cscl to the cell of 20 150mm culture dishes after collecting virus2Density gradient centrifugation,
Purified virus.Obtain high capacity adenoviral.
Embodiment 2:
For from the helper adenovirus Ad helper2 for removing packaging signal and pIX gene controlled expressions, the auxiliary gland
Organization of viral genome is characterized as that the N-terminal sequence of Cre genes is the DNA fragmentation of 5 ' ends of Cre gene coding regions, 4 base length,
DNA fragmentation of the Cre gene Cs terminal sequence for 3 ' ends of Cre gene coding regions, 1049 base length, adenoviral packaging signal is reversely puts
It puts, the DNA sequence dna being inserted between adenoviral gene group distance the 192nd, 5 ' ends base and the 5197th base is as follows:
ATAACTTCGTATAATGTATGCTATACGAAGTTATAAAACGCCAACTTTGACCCGGAACGCGGAAAACACCTGAGAAA
AACACCTGGGCGAGTCTCCACGTAAACGGTCAAAGTCCCCGCGGCCCTAGACAAATATTACGCGCTATGAGTAACAC
AAAATTATTCAGATTTCACTTCCTCTTATTCAGTTTTCCCGCGAAAATGGCCAAATCTTACTCGGTTACGCCCAAAT
TTACTACAACATCCGCCTAAAACCGCGCGAAAATTGTCACTTCCTGTGTAAAACGCAAGAGTCTTCTCTGTCTCGAC
AAGCCCAGTTTCTATTGGTCTCCTTAAACCTGTCTTGTAACCTTGATACTTACGCATGGTGGCATCTGACGGTTCAC
TAAACGAGCTCTGCTTATATAGACCTCCCACCGTACACGCCTACCGCCCATTTGCGTCAATGGGGCGGAGTTGTTAC
GACATTTTGGAAAGTCCCGTTGATTTTGGTGCCAAAACAAACTCCCATTGACGTCAATGGGGTGGAGACTTGGAAAT
CCCCGTGAGTCAAACCGCTATCCACGCCCATTGATGTACTGCCAAAACCGCATCACCATGGTAATAGCGATGACTAA
TACGTAGATGTACTGCCAAGTAGGAAAGTCCCATAAGGTCATGTACTGGGCATAATGCCAGGCGGGCCATTTACCGT
CATTGACGTCAATAGGGGGCGTACTTGGCATATGATACACTTGATGTACTGCCAAGTGGGCAGTTTACCGTAAATAC
TCCACCCATTGACGTCAATGGAAAGTCCCTATTGGCGTTACTATGGGAACATACGTCATTATTGACGTCAATGGGCG
GGGGTCGTTGGGCGGTCAGCCAGGCGGGCCATTTACCGTAAGTTATGTAACGCCACCGCGGGGACTAGAGTCGACCT
CATGGCTGCGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACA
GACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGCC
GGGATCATAATCAGCCATACCACATTTGTAGAGGTTTTACTTGCTTTAAAAAACCTCCCACACCTCCCCTGAACCTG
AAACATAAAATGAATGCAATTGTTGTTGTTAACTTGTTTATTGCAGCTTATAATGGTTACAAATAAAGCAATAGCAT
CACAAATTTCACAAATAAAGCATTTTTTTCACTGCATTCTAGTTGTGGTTTGTCCAAACTCATCAATGTATCTTATC
ATGTCTGGATCTCCCCGCGGTGCTAATCGCCATCTTCCAGCAGGCGCACCATTGCCCCTGTTTCACTATCCAGGTTA
CGGATATAGTTCATGACAATATTTACATTGGTCCAGCCACCAGCTTGCATGATCTCCGGTATTGAAACTCCAGCGCG
GGCCATATCTCGCGCGGCTCCGACACGGGCACTGTGTCCAGACCAGGCCAGGTATCTCTGACCAGAGTCATCCTTAG
CGCCGTAAATCAATCGATGAGTTGCTTCAAAAATCCCTTCCAGGGCGCGAGTTGATAGCTGGCTGGTGGCAGATGGC
GCGGCAACACCATTTTTTCTGACCCGGCAAAACAGGTAGTTATTCGGATCATCAGCTACACCAGAGACGGAAATCCA
TCGCTCGACCAGTTTAGTTACCCCCAGGCTAAGTGCCTTCTCTACACCTGCGGTGCTAACCAGCGTTTTCGTTCTGC
CAATATGGATTAACATTCTCCCACCGTCAGTACGTGAGATATCTTTAACCCTGATCCTGGCAATTTCGGCTATACGT
AACAGGGTGTTATAAGCAATCCCCAGAAATGCCAGATTACGTATATCCTGGCAGCGATCGCTATTTTCCATGAGTGA
ACGAACCTGGTCGAAATCAGTGCGTTCGAACGCTAGAGCCTGTTTTGCACGTTCACCGGCATCAACGTTTTCTTTTC
GGATCCGCCGCATAACCAGTGAAACAGCATTGCTGTCACTTGGTCGTGGCAGCCCGGACCGACGATGAAGCATGTTT
AGCTGGCCCAAATGTTGCTGGATAGTTTTTACTGCCAGACCGCGCGCCTGAAGATATAGAAGATAATCGCGAACATC
TTCAGGTTCTGCGGGAAACCATTTCCGGTTATTCAACTTGCACCATGCCGCCCACGACCGGCAAACGGACAGAAGCA
TTTTCCAGGTATGCTCAGAAAACGCCTGGCGATCCCTGAACATGTCCATCAGGTTCTTGCGAACCTCATCACTCGTT
GCATCGACCGGTAATGCAGGCAAATTTTGGTGTACGGTCAGTAAATTGGACACCTTCCTCTTCTTCTTGGCTGTGGA
GAGAAAGGCAAAGTGGATGTCAGTAAGACCAATAGGTGCCTATCATATAACTTCGTATAATGTATGCTATACGAAGT
TAT。
Other structures are identical with the Ad helper1 that embodiment 1 is previously mentioned.
Embodiment 3:
For from the helper adenovirus Ad helper3 for removing packaging signal and pIX gene controlled expressions, the auxiliary gland
Organization of viral genome is characterized as that the N-terminal sequence of Cre genes is the DNA pieces of 5 ' ends of Cre gene coding regions, 1049 base length
Section, DNA fragmentation of the Cre gene Cs terminal sequence for 3 ' ends of Cre gene coding regions, 4 base length, adenoviral packaging signal is reversely puts
It puts, the DNA sequence dna being inserted between adenoviral gene group distance the 192nd, 5 ' ends base and the 5197th base is as follows:
ATAACTTCGTATAGCATACATTATACGAAGTTATAAAACGCCAACTTTGACCCGGAACGCGGAAAACACCTGAGAAA
AACACCTGGGCGAGTCTCCACGTAAACGGTCAAAGTCCCCGCGGCCCTAGACAAATATTACGCGCTATGAGTAACAC
AAAATTATTCAGATTTCACTTCCTCTTATTCAGTTTTCCCGCGAAAATGGCCAAATCTTACTCGGTTACGCCCAAAT
TTACTACAACATCCGCCTAAAACCGCGCGAAAATTGTCACTTCCTGTGTAAAACGCAAGAGTCTTCTCTGTCTCGAC
AAGCCCAGTTTCTATTGGTCTCCTTAAACCTGTCTTGTAACCTTGATACTTACTCGCCATCTTCCAGCAGGCGCACC
ATTGCCCCTGTTTCACTATCCAGGTTACGGATATAGTTCATGACAATATTTACATTGGTCCAGCCACCAGCTTGCAT
GATCTCCGGTATTGAAACTCCAGCGCGGGCCATATCTCGCGCGGCTCCGACACGGGCACTGTGTCCAGACCAGGCCA
GGTATCTCTGACCAGAGTCATCCTTAGCGCCGTAAATCAATCGATGAGTTGCTTCAAAAATCCCTTCCAGGGCGCGA
GTTGATAGCTGGCTGGTGGCAGATGGCGCGGCAACACCATTTTTTCTGACCCGGCAAAACAGGTAGTTATTCGGATC
ATCAGCTACACCAGAGACGGAAATCCATCGCTCGACCAGTTTAGTTACCCCCAGGCTAAGTGCCTTCTCTACACCTG
CGGTGCTAACCAGCGTTTTCGTTCTGCCAATATGGATTAACATTCTCCCACCGTCAGTACGTGAGATATCTTTAACC
CTGATCCTGGCAATTTCGGCTATACGTAACAGGGTGTTATAAGCAATCCCCAGAAATGCCAGATTACGTATATCCTG
GCAGCGATCGCTATTTTCCATGAGTGAACGAACCTGGTCGAAATCAGTGCGTTCGAACGCTAGAGCCTGTTTTGCAC
GTTCACCGGCATCAACGTTTTCTTTTCGGATCCGCCGCATAACCAGTGAAACAGCATTGCTGTCACTTGGTCGTGGC
AGCCCGGACCGACGATGAAGCATGTTTAGCTGGCCCAAATGTTGCTGGATAGTTTTTACTGCCAGACCGCGCGCCTG
AAGATATAGAAGATAATCGCGAACATCTTCAGGTTCTGCGGGAAACCATTTCCGGTTATTCAACTTGCACCATGCCG
CCCACGACCGGCAAACGGACAGAAGCATTTTCCAGGTATGCTCAGAAAACGCCTGGCGATCCCTGAACATGTCCATC
AGGTTCTTGCGAACCTCATCACTCGTTGCATCGACCGGTAATGCAGGCAAATTTTGGTGTACGGTCAGTAAATTGGA
CACCTTCCTCTTCTTCTTGGGCATGGTGGCATCTGACGGTTCACTAAACGAGCTCTGCTTATATAGACCTCCCACCG
TACACGCCTACCGCCCATTTGCGTCAATGGGGCGGAGTTGTTACGACATTTTGGAAAGTCCCGTTGATTTTGGTGCC
AAAACAAACTCCCATTGACGTCAATGGGGTGGAGACTTGGAAATCCCCGTGAGTCAAACCGCTATCCACGCCCATTG
ATGTACTGCCAAAACCGCATCACCATGGTAATAGCGATGACTAATACGTAGATGTACTGCCAAGTAGGAAAGTCCCA
TAAGGTCATGTACTGGGCATAATGCCAGGCGGGCCATTTACCGTCATTGACGTCAATAGGGGGCGTACTTGGCATAT
GATACACTTGATGTACTGCCAAGTGGGCAGTTTACCGTAAATACTCCACCCATTGACGTCAATGGAAAGTCCCTATT
GGCGTTACTATGGGAACATACGTCATTATTGACGTCAATGGGCGGGGGTCGTTGGGCGGTCAGCCAGGCGGGCCATT
TACCGTAAGTTATGTAACGCCACCGCGGGGACTAGAGTCGACCTCATGGCTGCGCCCCGACACCCGCCAACACCCGC
TGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGT
GTCAAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGCCGGGATCATAATCAGCCATACCACATTTGTAGAG
GTTTTACTTGCTTTAAAAAACCTCCCACACCTCCCCTGAACCTGAAACATAAAATGAATGCAATTGTTGTTGTTAAC
TTGTTTATTGCAGCTTATAATGGTTACAAATAAAGCAATAGCATCACAAATTTCACAAATAAAGCATTTTTTTCACT
GCATTCTAGTTGTGGTTTGTCCAAACTCATCAATGTATCTTATCATGTCTGGATCTCCCCGCGGTGCTAACTGTGGA
GAGAAAGGCAAAGTGGATGTCAGTAAGACCAATAGGTGCCTATCATATAACTTCGTATAGCATACATTATACGAAGT
TAT。
Other structures are identical with the Ad helper1 that embodiment 1 is previously mentioned.
Nucleotide or amino acid sequence table
<110>Shaanxi Normal University
<120>A kind of helper adenovirus for being used to improve high capacity adenoviral packaging efficiency
<160>
<210> 1
<211> 2467
<212>What embodiment 1 was inserted between 5 type adenoviral gene group distance the 192nd, 5 ' ends base and the 5197th base
Sequence
<213> DNA
<220>
<400>
ATAACTTCGTATAATGTATGCTATACGAAGTTATTACACAGGAAGTGACAATTTTCGCGCGGTTTTAGGCGGA
TGTTGTAGTAAATTTGGGCGTAACCGAGTAAGATTTGGCCATTTTCGCGGGAAAACTGAATAAGAGGAAGTGAAATC
TGAATAATTTTGTGTTACTCATAGCGCGTAATATTTGTCTAGGGCCGCGGGGACTTTGACCGTTTACGTGGAGACTC
GCCCAGGTGTTTTTCTCAGGTGTTTTCCGCGTTCCGGGTCAAAGTTGGCGTTTTAAACGCAAGAGTCTTCTCTGTCT
CGACAAGCCCAGTTTCTATTGGTCTCCTTAAACCTGTCTTGTAACCTTGATACTTACCTGGTCGAAATCAGTGCGTT
CGAACGCTAGAGCCTGTTTTGCACGTTCACCGGCATCAACGTTTTCTTTTCGGATCCGCCGCATAACCAGTGAAACA
GCATTGCTGTCACTTGGTCGTGGCAGCCCGGACCGACGATGAAGCATGTTTAGCTGGCCCAAATGTTGCTGGATAGT
TTTTACTGCCAGACCGCGCGCCTGAAGATATAGAAGATAATCGCGAACATCTTCAGGTTCTGCGGGAAACCATTTCC
GGTTATTCAACTTGCACCATGCCGCCCACGACCGGCAAACGGACAGAAGCATTTTCCAGGTATGCTCAGAAAACGCC
TGGCGATCCCTGAACATGTCCATCAGGTTCTTGCGAACCTCATCACTCGTTGCATCGACCGGTAATGCAGGCAAATT
TTGGTGTACGGTCAGTAAATTGGACACCTTCCTCTTCTTCTTGGGCATGGTGGCATCTGACGGTTCACTAAACGAGC
TCTGCTTATATAGACCTCCCACCGTACACGCCTACCGCCCATTTGCGTCAATGGGGCGGAGTTGTTACGACATTTTG
GAAAGTCCCGTTGATTTTGGTGCCAAAACAAACTCCCATTGACGTCAATGGGGTGGAGACTTGGAAATCCCCGTGAG
TCAAACCGCTATCCACGCCCATTGATGTACTGCCAAAACCGCATCACCATGGTAATAGCGATGACTAATACGTAGAT
GTACTGCCAAGTAGGAAAGTCCCATAAGGTCATGTACTGGGCATAATGCCAGGCGGGCCATTTACCGTCATTGACGT
CAATAGGGGGCGTACTTGGCATATGATACACTTGATGTACTGCCAAGTGGGCAGTTTACCGTAAATACTCCACCCAT
TGACGTCAATGGAAAGTCCCTATTGGCGTTACTATGGGAACATACGTCATTATTGACGTCAATGGGCGGGGGTCGTT
GGGCGGTCAGCCAGGCGGGCCATTTACCGTAAGTTATGTAACGCCACCGCGGGGACTAGAGTCGACCTCATGGCTGC
GCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTG
TGACCGTCTCCGGGAGCTGCATGTGTCAAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGCCGGGATCATA
ATCAGCCATACCACATTTGTAGAGGTTTTACTTGCTTTAAAAAACCTCCCACACCTCCCCTGAACCTGAAACATAAA
ATGAATGCAATTGTTGTTGTTAACTTGTTTATTGCAGCTTATAATGGTTACAAATAAAGCAATAGCATCACAAATTT
CACAAATAAAGCATTTTTTTCACTGCATTCTAGTTGTGGTTTGTCCAAACTCATCAATGTATCTTATCATGTCTGGA
TCTCCCCGCGGTGCTAATCGCCATCTTCCAGCAGGCGCACCATTGCCCCTGTTTCACTATCCAGGTTACGGATATAG
TTCATGACAATATTTACATTGGTCCAGCCACCAGCTTGCATGATCTCCGGTATTGAAACTCCAGCGCGGGCCATATC
TCGCGCGGCTCCGACACGGGCACTGTGTCCAGACCAGGCCAGGTATCTCTGACCAGAGTCATCCTTAGCGCCGTAAA
TCAATCGATGAGTTGCTTCAAAAATCCCTTCCAGGGCGCGAGTTGATAGCTGGCTGGTGGCAGATGGCGCGGCAACA
CCATTTTTTCTGACCCGGCAAAACAGGTAGTTATTCGGATCATCAGCTACACCAGAGACGGAAATCCATCGCTCGAC
CAGTTTAGTTACCCCCAGGCTAAGTGCCTTCTCTACACCTGCGGTGCTAACCAGCGTTTTCGTTCTGCCAATATGGA
TTAACATTCTCCCACCGTCAGTACGTGAGATATCTTTAACCCTGATCCTGGCAATTTCGGCTATACGTAACAGGGTG
TTATAAGCAATCCCCAGAAATGCCAGATTACGTATATCCTGGCAGCGATCGCTATTTTCCATGAGTGAACGAACCTG
TGGAGAGAAAGGCAAAGTGGATGTCAGTAAGACCAATAGGTGCCTATCATATAACTTCGTATAATGTATGCTATACG
AAGTTAT。
<210> 2
<211> 2882
<212>Embodiment 1 interleaves 5 type adenoviral gene group distance the 27892nd, 5 ' ends base and the 30991st base
The pIX gene expression frames and IVa2 gene expression frames entered
<213> DNA
<220>
<400>
GTTACATAACTTACGGTAAATGGCCCGCCTGGCTGACCGCCCAACGACCCCCGCCCATTGACGTCAATAATGA
CGTATGTTCCCATAGTAACGCCAATAGGGACTTTCCATTGACGTCAATGGGTGGAGTATTTACGGTAAACTGCCCAC
TTGGCAGTACATCAAGTGTATCATATGCCAAGTACGCCCCCTATTGACGTCAATGACGGTAAATGGCCCGCCTGGCA
TTATGCCCAGTACATGACCTTATGGGACTTTCCTACTTGGCAGTACATCTACGTATTAGTCATCGCTATTACCATGG
TGATGCGGTTTTGGCAGTACATCAATGGGCGTGGATAGCGGTTTGACTCACGGGGATTTCCAAGTCTCCACCCCATT
GACGTCAATGGGAGTTTGTTTTGGCACCAAAATCAACGGGACTTTCCAAAATGTCGTAACAACTCCGCCCCATTGAC
GCAAATGGGCGGTAGGCGTGTACGGTGGGAGGTCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATATGAGCAC
CAACTCGTTTGATGGAAGCATTGTGAGCTCATATTTGACAACGCGCATGCCCCCATGGGCCGGGGTGCGTCAGAATG
TGATGGGCTCCAGCATTGATGGTCGCCCCGTCCTGCCCGCAAACTCTACTACCTTGACCTACGAGACCGTGTCTGGA
ACGCCGTTGGAGACTGCAGCCTCCGCCGCCGCTTCAGCCGCTGCAGCCACCGCCCGCGGGATTGTGACTGACTTTGC
TTTCCTGAGCCCGCTTGCAAGCAGTGCAGCTTCCCGTTCATCCGCCCGCGATGACAAGTTGACGGCTCTTTTGGCAC
AATTGGATTCTTTGACCCGGGAACTTAATGTCGTTTCTCAGCAGCTGTTGGATCTGCGCCAGCAGGTTTCTGCCCTG
AAGGCTTCCTCCCCTCCCAATGCGGTTTAAAACATAAATAAAAAACCAGACTCTGTTTGGATTTGGATCAAGCAAGT
GTCTTGCTGTCTTTATTTAGGGGTTTTGCGCGCGCGGTAGGCCCGGGACCAGCGGTCTCGGTCGTTGAGGGTCCTGT
GTATTTTTTCCAGGACGTGGTAAAGGTGACTCTGGATGTTCAGATACATGGGCATAAGCCCGTCTCTGGGGTGGAGG
TAGCACCACTGCAGAGCTTCATGCTGCGGGGTGGTGTTGTAGATGATCCAGTCGTAGCAGGAGCGCTGGGCGTGGTG
CCTAAAAATGTCTTTCAGTAGCAAGCTGATTGCCAGGGGCAGGCCCTTGGTGTAAGTGTTTACAAAGCGGTTAAGCT
GGGATGGGTGCATACGTGGGGATATGAGATGCATCTTGGACTGTATTTTTAGGTTGGCTATGTTCCCAGCCATATCC
CTCCGGGGATTCATGTTGTGCAGAACCACCAGCACAGTGTATCCGGTGCACTTGGGAAATTTGTCATGTAGCTTAGA
AGGAAATGCGTGGAAGAACTTGGAGACGCCCTTGTGACCTCCAAGATTTTCCATGCATTCGTCCATAATGATGGCAA
TGGGCCCACGGGCGGCGGCCTGGGCGAAGATATTTCTGGGATCACTAACGTCATAGTTGTGTTCCAGGATGAGATCG
TCATAGGCCATTTTTACAAAGCGCGGGCGGAGGGTGCCAGACTGCGGTATAATGGTTCCATCCGGCCCAGGGGCGTA
GTTACCCTCACAGATTTGCATTTCCCACGCTTTGAGTTCAGATGGGGGGATCATGTCTACCTGCGGGGCGATGAAGA
AAACGGTTTCCGGGGTAGGGGAGATCAGCTGGGAAGAAAGCAGGTTCCTGAGCAGCTGCGACTTACCGCAGCCGGTG
GGCCCGTAAATCACACCTATTACCGGGTGCAACTGGTAGTTAAGAGAGCTGCAGCTGCCGTCATCCCTGAGCAGGGG
GGCCACTTCGTTAAGCATGTCCCTGACTCGCATGTTTTCCCTGACCAAATCCGCCAGAAGGCGCTCGCCGCCCAGCG
ATAGCAGTTCTTGCAAGGAAGCAAAGTTTTTCAACGGTTTGAGACCGTCCGCCGTAGGCATGCTTTTGAGCGTTTGA
CCAAGCAGTTCCAGGCGGTCCCACAGCTCGGTCACCTGCTCTACGGCATCTCGATCCAGCATATCTCCTCGTTTCGC
GGGTTGGGGCGGCTTTCGCTGTACGGCAGTAGTCGGTGCTCGTCCAGACGGGCCAGGGTCATGTCTTTCCACGGGCG
CAGGGTCCTCGTCAGCGTAGTCTGGGTCACGGTGAAGGGGTGCGCTCCGGGCTGCGCGCTGGCCAGGGTGCGCTTGA
GGCTGGTCCTGCTGGTGCTGAAGCGCTGCCGGTCTTCGCCCTCTGGTTTCCATGGGCTGCAGGTCGAAAGGCCCGGA
GATGAGGAAGAGGAGAACAGCGCGGCAGACGTGCGCTTTTGAAGCGTGCAGAATGCCGGGCCTCCGGAGGACCTTCG
GGCGCCCGCCCCGCCCCTGAGCCCGCCCCTGAGCCCGCCCCCGGACCCACCCCTTCCCAGCCTCTGAGCCCAGAAAG
CGAAGGAGCAAAGCTGCTATTGGCCGCTGCCCCAAAGGCCTACCCGCTTCCATTGCTCAGCGGTGCTGTCCATCTGC
ACGAGACTAGCTAGTAGTGAGACGTGCTACTCCCATTTGTCACGTCCTGCACGACGCGAGCTGCGGGGCGGGGGGGA
ACTTCCTGACTAGGGGAGGAGTAGAAGGTGGCGCGAAGGGGCCACCAAAGAACGGAGCCGGTTGGCGCCTACCGGTG
GATGTGGAATGTGTGCGAGGCCAGAGGCCACTTGTGTAGCGCCAAGTGCCCAGCGGGGCTGCTAAAGCGCATGCTCC
AGACTGCCTTGGGAAAAGCGCCTCCCCTACCCGGTAT。
<210> 3
<211> 37
<212>Primer P1 EPXN for
<213> DNA
<220>
<400>
AATTTTAATTAATTCTCGAGAATCGATAAGCGGCCGC。
<210> 4
<211> 37
<212>Primer P2 EPXN reverse
<213> DNA
<220>
<400>
AGCTGCGGCCGCTTATCGATTCTCGAGAATTAATTAA。
<210> 5
<211> 33
<212>Primer P3 E3 up PacI for
<213> DNA
<220>
<400>
ATTAATTAAatcgacccgcgagcttagaaacag。
<210> 6
<211> 31
<212>Primer P4 E3 up XhoI reverse
<213> DNA
<220>
<400>
ACTCGAGtttcaggcgcagttgctctgcctc。
<210> 7
<211> 30
<212>Primer P5 E3 down ClaI for
<213> DNA
<220>
<400>
AATCGATgtttcctcctgttcctgtccatc。
<210> 8
<211> 31
<212>Primer P6 E3 down NotI reverse
<213> DNA
<220>
<400>
AGCGGCCGCtgagctgcccggggagtttatt。
<210> 9
<211> 31
<212>Primer CMV XhoI for
<213> DNA
<220>
<400>
ACTCGAGGTTACATAACTTACGGTAAATGGC。
<210> 10
<211> 51
<212>Primer CMV pIX overlap reverse
<213> DNA
<220>
<400>
ttccatcaaacgagttggtgctcatATCTGACGGTTCACTAAACGAGCTCT。
<210> 11
<211> 25
<212>Primer pIX for
<213> DNA
<220>
<400>
Atgagcaccaactcgtttgatggaa。
<210> 12
<211> 32
<212>Primer I va2 reverse
<213> DNA
<220>
<400>
Atggaaaccagagggcgaagaccggcagcgct。
<210> 13
<211> 34
<212>Primer EF1 α ClaI for
<213> DNA
<220>
<400>
AATCGATAAGGATCTGCGATCGCTCCGGTGCCCG
<210> 14
<211> 53
<212>Primer EF1 α Iva2 overlap reverse
<213> DNA
<220>
<400>
AGCGCTGCCGGTCTTCGCCCTCTGGTTTCCATGGTGGCGTCTAGCGTAGGCGC。
<210> 15
<211> 30
<212>Primer helperE1 down ClaII for
<213> DNA
<220>
<400>
AATCGATctacggcatctcgatccagcata。
<210> 16
<211> 30
<212>Primer helperE1 down NotI reverse
<213> DNA
<220>
<400>
AGCGGCCGCgggccaggtgaatatcaaatc。
<210> 17
<211> 2674
<212>ITR-loxp- Ψ-cre-loxp segments
<213> DNA
<220>
<400>
TTAATTAAcatcatcaataatataccttattttggattgaagccaatatgataatgagggggtggagtttgtg
acgtggcgcggggcgtgggaacggggcgggtgacgtagtagtgtggcggaagtgtgatgttgcaagtgtggcggaac
acatgtaagcgacggatgtggcaaaagtgacgtttttggtgtgcgccggtgATAACTTCGTATAATGTATGCTATAC
GAAGTTATTACACAGGAAGTGACAATTTTCGCGCGGTTTTAGGCGGATGTTGTAGTAAATTTGGGCGTAACCGAGTA
AGATTTGGCCATTTTCGCGGGAAAACTGAATAAGAGGAAGTGAAATCTGAATAATTTTGTGTTACTCATAGCGCGTA
ATATTTGTCTAGGGCCGCGGGGACTTTGACCGTTTACGTGGAGACTCGCCCAGGTGTTTTTCTCAGGTGTTTTCCGC
GTTCCGGGTCAAAGTTGGCGTTTTAAACGCAAGAGTCTTCTCTGTCTCGACAAGCCCAGTTTCTATTGGTCTCCTTA
AACCTGTCTTGTAACCTTGATACTTACCTGGTCGAAATCAGTGCGTTCGAACGCTAGAGCCTGTTTTGCACGTTCAC
CGGCATCAACGTTTTCTTTTCGGATCCGCCGCATAACCAGTGAAACAGCATTGCTGTCACTTGGTCGTGGCAGCCCG
GACCGACGATGAAGCATGTTTAGCTGGCCCAAATGTTGCTGGATAGTTTTTACTGCCAGACCGCGCGCCTGAAGATA
TAGAAGATAATCGCGAACATCTTCAGGTTCTGCGGGAAACCATTTCCGGTTATTCAACTTGCACCATGCCGCCCACG
ACCGGCAAACGGACAGAAGCATTTTCCAGGTATGCTCAGAAAACGCCTGGCGATCCCTGAACATGTCCATCAGGTTC
TTGCGAACCTCATCACTCGTTGCATCGACCGGTAATGCAGGCAAATTTTGGTGTACGGTCAGTAAATTGGACACCTT
CCTCTTCTTCTTGGGCATGGTGGCATCTGACGGTTCACTAAACGAGCTCTGCTTATATAGACCTCCCACCGTACACG
CCTACCGCCCATTTGCGTCAATGGGGCGGAGTTGTTACGACATTTTGGAAAGTCCCGTTGATTTTGGTGCCAAAACA
AACTCCCATTGACGTCAATGGGGTGGAGACTTGGAAATCCCCGTGAGTCAAACCGCTATCCACGCCCATTGATGTAC
TGCCAAAACCGCATCACCATGGTAATAGCGATGACTAATACGTAGATGTACTGCCAAGTAGGAAAGTCCCATAAGGT
CATGTACTGGGCATAATGCCAGGCGGGCCATTTACCGTCATTGACGTCAATAGGGGGCGTACTTGGCATATGATACA
CTTGATGTACTGCCAAGTGGGCAGTTTACCGTAAATACTCCACCCATTGACGTCAATGGAAAGTCCCTATTGGCGTT
ACTATGGGAACATACGTCATTATTGACGTCAATGGGCGGGGGTCGTTGGGCGGTCAGCCAGGCGGGCCATTTACCGT
AAGTTATGTAACGCCACCGCGGGGACTAGAGTCGACCTCATGGCTGCGCCCCGACACCCGCCAACACCCGCTGACGC
GCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAAG
AGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGCCGGGATCATAATCAGCCATACCACATTTGTAGAGGTTTTA
CTTGCTTTAAAAAACCTCCCACACCTCCCCTGAACCTGAAACATAAAATGAATGCAATTGTTGTTGTTAACTTGTTT
ATTGCAGCTTATAATGGTTACAAATAAAGCAATAGCATCACAAATTTCACAAATAAAGCATTTTTTTCACTGCATTC
TAGTTGTGGTTTGTCCAAACTCATCAATGTATCTTATCATGTCTGGATCTCCCCGCGGTGCTAATCGCCATCTTCCA
GCAGGCGCACCATTGCCCCTGTTTCACTATCCAGGTTACGGATATAGTTCATGACAATATTTACATTGGTCCAGCCA
CCAGCTTGCATGATCTCCGGTATTGAAACTCCAGCGCGGGCCATATCTCGCGCGGCTCCGACACGGGCACTGTGTCC
AGACCAGGCCAGGTATCTCTGACCAGAGTCATCCTTAGCGCCGTAAATCAATCGATGAGTTGCTTCAAAAATCCCTT
CCAGGGCGCGAGTTGATAGCTGGCTGGTGGCAGATGGCGCGGCAACACCATTTTTTCTGACCCGGCAAAACAGGTAG
TTATTCGGATCATCAGCTACACCAGAGACGGAAATCCATCGCTCGACCAGTTTAGTTACCCCCAGGCTAAGTGCCTT
CTCTACACCTGCGGTGCTAACCAGCGTTTTCGTTCTGCCAATATGGATTAACATTCTCCCACCGTCAGTACGTGAGA
TATCTTTAACCCTGATCCTGGCAATTTCGGCTATACGTAACAGGGTGTTATAAGCAATCCCCAGAAATGCCAGATTA
CGTATATCCTGGCAGCGATCGCTATTTTCCATGAGTGAACGAACCTGTGGAGAGAAAGGCAAAGTGGATGTCAGTAA
GACCAATAGGTGCCTATCATATAACTTCGTATAATGTATGCTATACGAAGTTATCTCGAG。
<210> 18
<211> 2467
<212>Embodiment 2 is sequentially inserted between adenoviral gene group distance the 192nd, 5 ' ends base and the 5197th base
Sequence
<213> DNA
<220>
<400>
ATAACTTCGTATAATGTATGCTATACGAAGTTATAAAACGCCAACTTTGACCCGGAACGCGGAAAACACCTGA
GAAAAACACCTGGGCGAGTCTCCACGTAAACGGTCAAAGTCCCCGCGGCCCTAGACAAATATTACGCGCTATGAGTA
ACACAAAATTATTCAGATTTCACTTCCTCTTATTCAGTTTTCCCGCGAAAATGGCCAAATCTTACTCGGTTACGCCC
AAATTTACTACAACATCCGCCTAAAACCGCGCGAAAATTGTCACTTCCTGTGTAAAACGCAAGAGTCTTCTCTGTCT
CGACAAGCCCAGTTTCTATTGGTCTCCTTAAACCTGTCTTGTAACCTTGATACTTACGCATGGTGGCATCTGACGGT
TCACTAAACGAGCTCTGCTTATATAGACCTCCCACCGTACACGCCTACCGCCCATTTGCGTCAATGGGGCGGAGTTG
TTACGACATTTTGGAAAGTCCCGTTGATTTTGGTGCCAAAACAAACTCCCATTGACGTCAATGGGGTGGAGACTTGG
AAATCCCCGTGAGTCAAACCGCTATCCACGCCCATTGATGTACTGCCAAAACCGCATCACCATGGTAATAGCGATGA
CTAATACGTAGATGTACTGCCAAGTAGGAAAGTCCCATAAGGTCATGTACTGGGCATAATGCCAGGCGGGCCATTTA
CCGTCATTGACGTCAATAGGGGGCGTACTTGGCATATGATACACTTGATGTACTGCCAAGTGGGCAGTTTACCGTAA
ATACTCCACCCATTGACGTCAATGGAAAGTCCCTATTGGCGTTACTATGGGAACATACGTCATTATTGACGTCAATG
GGCGGGGGTCGTTGGGCGGTCAGCCAGGCGGGCCATTTACCGTAAGTTATGTAACGCCACCGCGGGGACTAGAGTCG
ACCTCATGGCTGCGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCT
TACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGGC
AGCCGGGATCATAATCAGCCATACCACATTTGTAGAGGTTTTACTTGCTTTAAAAAACCTCCCACACCTCCCCTGAA
CCTGAAACATAAAATGAATGCAATTGTTGTTGTTAACTTGTTTATTGCAGCTTATAATGGTTACAAATAAAGCAATA
GCATCACAAATTTCACAAATAAAGCATTTTTTTCACTGCATTCTAGTTGTGGTTTGTCCAAACTCATCAATGTATCT
TATCATGTCTGGATCTCCCCGCGGTGCTAATCGCCATCTTCCAGCAGGCGCACCATTGCCCCTGTTTCACTATCCAG
GTTACGGATATAGTTCATGACAATATTTACATTGGTCCAGCCACCAGCTTGCATGATCTCCGGTATTGAAACTCCAG
CGCGGGCCATATCTCGCGCGGCTCCGACACGGGCACTGTGTCCAGACCAGGCCAGGTATCTCTGACCAGAGTCATCC
TTAGCGCCGTAAATCAATCGATGAGTTGCTTCAAAAATCCCTTCCAGGGCGCGAGTTGATAGCTGGCTGGTGGCAGA
TGGCGCGGCAACACCATTTTTTCTGACCCGGCAAAACAGGTAGTTATTCGGATCATCAGCTACACCAGAGACGGAAA
TCCATCGCTCGACCAGTTTAGTTACCCCCAGGCTAAGTGCCTTCTCTACACCTGCGGTGCTAACCAGCGTTTTCGTT
CTGCCAATATGGATTAACATTCTCCCACCGTCAGTACGTGAGATATCTTTAACCCTGATCCTGGCAATTTCGGCTAT
ACGTAACAGGGTGTTATAAGCAATCCCCAGAAATGCCAGATTACGTATATCCTGGCAGCGATCGCTATTTTCCATGA
GTGAACGAACCTGGTCGAAATCAGTGCGTTCGAACGCTAGAGCCTGTTTTGCACGTTCACCGGCATCAACGTTTTCT
TTTCGGATCCGCCGCATAACCAGTGAAACAGCATTGCTGTCACTTGGTCGTGGCAGCCCGGACCGACGATGAAGCAT
GTTTAGCTGGCCCAAATGTTGCTGGATAGTTTTTACTGCCAGACCGCGCGCCTGAAGATATAGAAGATAATCGCGAA
CATCTTCAGGTTCTGCGGGAAACCATTTCCGGTTATTCAACTTGCACCATGCCGCCCACGACCGGCAAACGGACAGA
AGCATTTTCCAGGTATGCTCAGAAAACGCCTGGCGATCCCTGAACATGTCCATCAGGTTCTTGCGAACCTCATCACT
CGTTGCATCGACCGGTAATGCAGGCAAATTTTGGTGTACGGTCAGTAAATTGGACACCTTCCTCTTCTTCTTGGCTG
TGGAGAGAAAGGCAAAGTGGATGTCAGTAAGACCAATAGGTGCCTATCATATAACTTCGTATAATGTATGCTATACG
AAGTTAT。
<210> 19
<211> 2467
<212>Embodiment 3 is sequentially inserted between adenoviral gene group distance the 192nd, 5 ' ends base and the 5197th base
Sequence
<213> DNA
<220>
<400>
ATAACTTCGTATAGCATACATTATACGAAGTTATAAAACGCCAACTTTGACCCGGAACGCGGAAAACACCTGA
GAAAAACACCTGGGCGAGTCTCCACGTAAACGGTCAAAGTCCCCGCGGCCCTAGACAAATATTACGCGCTATGAGTA
ACACAAAATTATTCAGATTTCACTTCCTCTTATTCAGTTTTCCCGCGAAAATGGCCAAATCTTACTCGGTTACGCCC
AAATTTACTACAACATCCGCCTAAAACCGCGCGAAAATTGTCACTTCCTGTGTAAAACGCAAGAGTCTTCTCTGTCT
CGACAAGCCCAGTTTCTATTGGTCTCCTTAAACCTGTCTTGTAACCTTGATACTTACTCGCCATCTTCCAGCAGGCG
CACCATTGCCCCTGTTTCACTATCCAGGTTACGGATATAGTTCATGACAATATTTACATTGGTCCAGCCACCAGCTT
GCATGATCTCCGGTATTGAAACTCCAGCGCGGGCCATATCTCGCGCGGCTCCGACACGGGCACTGTGTCCAGACCAG
GCCAGGTATCTCTGACCAGAGTCATCCTTAGCGCCGTAAATCAATCGATGAGTTGCTTCAAAAATCCCTTCCAGGGC
GCGAGTTGATAGCTGGCTGGTGGCAGATGGCGCGGCAACACCATTTTTTCTGACCCGGCAAAACAGGTAGTTATTCG
GATCATCAGCTACACCAGAGACGGAAATCCATCGCTCGACCAGTTTAGTTACCCCCAGGCTAAGTGCCTTCTCTACA
CCTGCGGTGCTAACCAGCGTTTTCGTTCTGCCAATATGGATTAACATTCTCCCACCGTCAGTACGTGAGATATCTTT
AACCCTGATCCTGGCAATTTCGGCTATACGTAACAGGGTGTTATAAGCAATCCCCAGAAATGCCAGATTACGTATAT
CCTGGCAGCGATCGCTATTTTCCATGAGTGAACGAACCTGGTCGAAATCAGTGCGTTCGAACGCTAGAGCCTGTTTT
GCACGTTCACCGGCATCAACGTTTTCTTTTCGGATCCGCCGCATAACCAGTGAAACAGCATTGCTGTCACTTGGTCG
TGGCAGCCCGGACCGACGATGAAGCATGTTTAGCTGGCCCAAATGTTGCTGGATAGTTTTTACTGCCAGACCGCGCG
CCTGAAGATATAGAAGATAATCGCGAACATCTTCAGGTTCTGCGGGAAACCATTTCCGGTTATTCAACTTGCACCAT
GCCGCCCACGACCGGCAAACGGACAGAAGCATTTTCCAGGTATGCTCAGAAAACGCCTGGCGATCCCTGAACATGTC
CATCAGGTTCTTGCGAACCTCATCACTCGTTGCATCGACCGGTAATGCAGGCAAATTTTGGTGTACGGTCAGTAAAT
TGGACACCTTCCTCTTCTTCTTGGGCATGGTGGCATCTGACGGTTCACTAAACGAGCTCTGCTTATATAGACCTCCC
ACCGTACACGCCTACCGCCCATTTGCGTCAATGGGGCGGAGTTGTTACGACATTTTGGAAAGTCCCGTTGATTTTGG
TGCCAAAACAAACTCCCATTGACGTCAATGGGGTGGAGACTTGGAAATCCCCGTGAGTCAAACCGCTATCCACGCCC
ATTGATGTACTGCCAAAACCGCATCACCATGGTAATAGCGATGACTAATACGTAGATGTACTGCCAAGTAGGAAAGT
CCCATAAGGTCATGTACTGGGCATAATGCCAGGCGGGCCATTTACCGTCATTGACGTCAATAGGGGGCGTACTTGGC
ATATGATACACTTGATGTACTGCCAAGTGGGCAGTTTACCGTAAATACTCCACCCATTGACGTCAATGGAAAGTCCC
TATTGGCGTTACTATGGGAACATACGTCATTATTGACGTCAATGGGCGGGGGTCGTTGGGCGGTCAGCCAGGCGGGC
CATTTACCGTAAGTTATGTAACGCCACCGCGGGGACTAGAGTCGACCTCATGGCTGCGCCCCGACACCCGCCAACAC
CCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGC
ATGTGTCAAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGCCGGGATCATAATCAGCCATACCACATTTGT
AGAGGTTTTACTTGCTTTAAAAAACCTCCCACACCTCCCCTGAACCTGAAACATAAAATGAATGCAATTGTTGTTGT
TAACTTGTTTATTGCAGCTTATAATGGTTACAAATAAAGCAATAGCATCACAAATTTCACAAATAAAGCATTTTTTT
CACTGCATTCTAGTTGTGGTTTGTCCAAACTCATCAATGTATCTTATCATGTCTGGATCTCCCCGCGGTGCTAACTG
TGGAGAGAAAGGCAAAGTGGATGTCAGTAAGACCAATAGGTGCCTATCATATAACTTCGTATAGCATACATTATACG
AAGTTAT。
Claims (8)
1. a kind of helper adenovirus for being used to improve high capacity adenoviral packaging efficiency, which is characterized in that with 5 type adenoviral genes
Based on group, the DNA sequence dna and 27893bp that eliminate between 5 type adenoviral gene group distance, 5 ' ends 193bp to 5196bp arrive
DNA sequence dna between 30990bp;Between 5 type adenoviral gene group distance the 192nd, 5 ' ends base and the 5197th base according to
Secondary insertion loxp sequences, adenoviral packaging signal Ψ, Cre gene expression frame, loxp sequences, two loxp sequences directions of insertion
It is consistent;PIX genes are inserted between 5 type adenoviral gene group distance the 27892nd, 5 ' ends base and the 30991st base
Expression cassette and IVa2 gene expression frames.
2. the helper adenovirus as described in claim 1 for being used to improve adenovirus packaging efficiency, which is characterized in that the gland
Viral packaging signal Ψ is the packaging signal of 5 type adenovirus, the 193rd, 5 ' ends of specially 5 type adenoviral gene group distance base
DNA sequence dna between the 440th base, direction is forward or backwards.
3. the helper adenovirus as described in claim 1 for being used to improve adenovirus packaging efficiency, which is characterized in that described
Cre gene expression frames are made of promoter, Cre genes, terminator;Wherein, Cre gene orders include N-terminal sequence, C-terminal sequence,
Introne shearing donor sequences, introne shearing receptor sequence, N-terminal sequence is Cre gene coding regions 4,5 ' ends base to 1049
The DNA fragmentation of a base length, C-terminal sequence are the DNA fragmentation that Cre gene coding regions 4,3 ' ends base is grown to 1049 bases,
One section of introne shearing donor sequences is inserted at 3 ' ends of N-terminal sequence, and one section of introne shearing receptor is inserted at 5 ' ends of C-terminal sequence
Sequence, introne shearing donor sequences and shearing receptor sequence total length are no more than 500bp;Introne shearing donor sequences, Cre
Gene N-terminal sequence, promoter, terminator, Cre gene Cs terminal sequence, introne shear receptor sequence successively according to 3 ' to the side of 5 '
To the 3 ' ends for being inserted into adenoviral packaging signal Ψ.
4. the helper adenovirus for being used to improve adenovirus packaging efficiency as described in claim 1 or 3, which is characterized in that described
Cre gene expression frame sequences it is as follows:
AAACGCAAGAGTCTTCTCTGTCTCGACAAGCCCAGTTTCTATTGGTCTCCTTAAACCTGTCTTGTAACCTTGA
TACTTACCTGGTCGAAATCAGTGCGTTCGAACGCTAGAGCCTGTTTTGCACGTTCACCGGCATCAACGTTTTCTTTT
CGGATCCGCCGCATAACCAGTGAAACAGCATTGCTGTCACTTGGTCGTGGCAGCCCGGACCGACGATGAAGCATGTT
TAGCTGGCCCAAATGTTGCTGGATAGTTTTTACTGCCAGACCGCGCGCCTGAAGATATAGAAGATAATCGCGAACAT
CTTCAGGTTCTGCGGGAAACCATTTCCGGTTATTCAACTTGCACCATGCCGCCCACGACCGGCAAACGGACAGAAGC
ATTTTCCAGGTATGCTCAGAAAACGCCTGGCGATCCCTGAACATGTCCATCAGGTTCTTGCGAACCTCATCACTCGT
TGCATCGACCGGTAATGCAGGCAAATTTTGGTGTACGGTCAGTAAATTGGACACCTTCCTCTTCTTCTTGGGCATGG
TGGCATCTGACGGTTCACTAAACGAGCTCTGCTTATATAGACCTCCCACCGTACACGCCTACCGCCCATTTGCGTCA
ATGGGGCGGAGTTGTTACGACATTTTGGAAAGTCCCGTTGATTTTGGTGCCAAAACAAACTCCCATTGACGTCAATG
GGGTGGAGACTTGGAAATCCCCGTGAGTCAAACCGCTATCCACGCCCATTGATGTACTGCCAAAACCGCATCACCAT
GGTAATAGCGATGACTAATACGTAGATGTACTGCCAAGTAGGAAAGTCCCATAAGGTCATGTACTGGGCATAATGCC
AGGCGGGCCATTTACCGTCATTGACGTCAATAGGGGGCGTACTTGGCATATGATACACTTGATGTACTGCCAAGTGG
GCAGTTTACCGTAAATACTCCACCCATTGACGTCAATGGAAAGTCCCTATTGGCGTTACTATGGGAACATACGTCAT
TATTGACGTCAATGGGCGGGGGTCGTTGGGCGGTCAGCCAGGCGGGCCATTTACCGTAAGTTATGTAACGCCACCGC
GGGGACTAGAGTCGACCTCATGGCTGCGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGC
TCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAAGAGGTTTTCACCGTCATCACC
GAAACGCGCGAGGCAGCCGGGATCATAATCAGCCATACCACATTTGTAGAGGTTTTACTTGCTTTAAAAAACCTCCC
ACACCTCCCCTGAACCTGAAACATAAAATGAATGCAATTGTTGTTGTTAACTTGTTTATTGCAGCTTATAATGGTTA
CAAATAAAGCAATAGCATCACAAATTTCACAAATAAAGCATTTTTTTCACTGCATTCTAGTTGTGGTTTGTCCAAAC
TCATCAATGTATCTTATCATGTCTGGATCTCCCCGCGGTGCTAATCGCCATCTTCCAGCAGGCGCACCATTGCCCCT
GTTTCACTATCCAGGTTACGGATATAGTTCATGACAATATTTACATTGGTCCAGCCACCAGCTTGCATGATCTCCGG
TATTGAAACTCCAGCGCGGGCCATATCTCGCGCGGCTCCGACACGGGCACTGTGTCCAGACCAGGCCAGGTATCTCT
GACCAGAGTCATCCTTAGCGCCGTAAATCAATCGATGAGTTGCTTCAAAAATCCCTTCCAGGGCGCGAGTTGATAGC
TGGCTGGTGGCAGATGGCGCGGCAACACCATTTTTTCTGACCCGGCAAAACAGGTAGTTATTCGGATCATCAGCTAC
ACCAGAGACGGAAATCCATCGCTCGACCAGTTTAGTTACCCCCAGGCTAAGTGCCTTCTCTACACCTGCGGTGCTAA
CCAGCGTTTTCGTTCTGCCAATATGGATTAACATTCTCCCACCGTCAGTACGTGAGATATCTTTAACCCTGATCCTG
GCAATTTCGGCTATACGTAACAGGGTGTTATAAGCAATCCCCAGAAATGCCAGATTACGTATATCCTGGCAGCGATC
GCTATTTTCCATGAGTGAACGAACCTGTGGAGAGAAAGGCAAAGTGGATGTCAGTAAGACCAATAGGTGCCTATCAT
。
5. the helper adenovirus as described in claim 1 for being used to improve adenovirus packaging efficiency, which is characterized in that described
PIX gene expression frames are to be separately added into promoter and terminator at 5 ' ends of the pIX gene coding regions of 5 type adenovirus and 3 ' ends;
The IVa2 gene expressions are to be separately added into promoter and end at 5 ' ends of the IVa2 gene coding regions of 5 type adenovirus and 3 ' ends
It is only sub.
6. the helper adenovirus for being used to improve adenovirus packaging efficiency as described in claim 3 or 5, which is characterized in that described
Promoter be eukaryotic promoter, the terminator is eucaryon terminator.
7. the helper adenovirus for being used to improve adenovirus packaging efficiency as described in claim 3 or 5, which is characterized in that described
Promoter be any one in CMV, EF1 α, PGK, SV40, CAG, Tet on, Tet off, the terminator is
Any one in SV40pA, BGHpA, TKpA, hGHpA.
8. the helper adenovirus as claimed in claim 6 for being used to improve adenovirus packaging efficiency, which is characterized in that described opens
Mover is any one in CMV, EF1 α, PGK, SV40, CAG, Tet on, Tet off, the terminator be SV40pA,
Any one in BGHpA, TKpA, hGHpA.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711239774.XA CN108203706B (en) | 2017-11-30 | 2017-11-30 | Helper adenovirus for improving packaging efficiency of high-capacity adenovirus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711239774.XA CN108203706B (en) | 2017-11-30 | 2017-11-30 | Helper adenovirus for improving packaging efficiency of high-capacity adenovirus |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108203706A true CN108203706A (en) | 2018-06-26 |
CN108203706B CN108203706B (en) | 2021-03-26 |
Family
ID=62604505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711239774.XA Active CN108203706B (en) | 2017-11-30 | 2017-11-30 | Helper adenovirus for improving packaging efficiency of high-capacity adenovirus |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108203706B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999025861A2 (en) * | 1997-11-17 | 1999-05-27 | Aventis Pharma S.A. | Adenovirus vectors and method for reducing homologous recombination phenomena |
CN1342206A (en) * | 1998-08-28 | 2002-03-27 | 杜克大学 | Adenoviruses deleted in IVa2, 100K and/or preterminal protein sequences |
CN102099481A (en) * | 2008-05-16 | 2011-06-15 | 西马生物医学计划公司 | Self-inactivating helper adenoviruses for the production of high-capacity recombinant adenoviruses |
-
2017
- 2017-11-30 CN CN201711239774.XA patent/CN108203706B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999025861A2 (en) * | 1997-11-17 | 1999-05-27 | Aventis Pharma S.A. | Adenovirus vectors and method for reducing homologous recombination phenomena |
CN1342206A (en) * | 1998-08-28 | 2002-03-27 | 杜克大学 | Adenoviruses deleted in IVa2, 100K and/or preterminal protein sequences |
CN102099481A (en) * | 2008-05-16 | 2011-06-15 | 西马生物医学计划公司 | Self-inactivating helper adenoviruses for the production of high-capacity recombinant adenoviruses |
Also Published As
Publication number | Publication date |
---|---|
CN108203706B (en) | 2021-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Parks et al. | An enhanced system for construction of adenoviral vectors by the two-plasmid rescue method | |
EP1056881B1 (en) | A simplified system for generating recombinant adenoviruses | |
Parks et al. | A high-efficiency Cre/loxP-based system for construction of adenoviral vectors | |
Appaiahgari et al. | Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls | |
Ng et al. | Development of a FLP/frt system for generating helper-dependent adenoviral vectors | |
Youil et al. | Hexon gene switch strategy for the generation of chimeric recombinant adenovirus | |
Legrand et al. | Fiberless recombinant adenoviruses: virus maturation and infectivity in the absence of fiber | |
Li et al. | Adenovirus vectors in hematopoietic stem cell genome editing | |
CN107630004B (en) | Cell strain for reducing generation of replication-competent adenovirus and construction method and application thereof | |
US20210269827A1 (en) | Modified serotype 28 adenoviral vectors | |
CN109295096A (en) | Adenovirus system and recombination adenovirus construction method | |
CN103937835A (en) | Expression vector based on adenovirus AdC68 and construction method thereof | |
Ng et al. | Yeast recombinase FLP functions effectively in human cells for construction of adenovirus vectors | |
Fujita et al. | Gene targeting with a replication-defective adenovirus vector | |
SK4412001A3 (en) | Selectively replicating viral vectors | |
CN108203706A (en) | A kind of helper adenovirus for being used to improve high capacity adenoviral packaging efficiency | |
WO2006125381A1 (en) | Tumor targeting gene-virus zd55-il-24, construction method and application thereof | |
Yu et al. | A simplified system for generating recombinant E3-deleted canine adenovirus-2 | |
Richards et al. | The admid system: generation of recombinant adenoviruses by Tn7-mediated transposition in E. coli | |
Wu et al. | Generation of a replication-deficient recombinant human adenovirus type 35 vector using bacteria-mediated homologous recombination | |
Renaut et al. | A rapid and easy method for production and selection of recombinant adenovirus genomes | |
Hurez et al. | Gene delivery into primary T cells: overview and characterization of a transgenic model for efficient adenoviral transduction | |
CN113774031B (en) | Replication type human adenovirus and application thereof | |
CN102559758B (en) | Vector for preparing adenovirus of which hexon is subjected to genetic modification and method for constructing vector | |
Danthinne | Simultaneous insertion of two expression cassettes into adenovirus vectors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |